TGR-1202 in Combination with Ibrutinib in Patients with Relapsed or Refractory CLL or MCL: Preliminary Results of a Multicenter Phase I/Ib Study
暂无分享，去创建一个
M. Davids | D. Fisher | C. Jacobson | Jennifer R. Brown | J. Rueter | A. Bashey | Haesook T. Kim | A. Boruchov | J. Arnason | P. Sportelli | L. Stampleman | H. Miskin | K. Francoeur | A. Nicotra | A. Savell | J. M. Hellman